A phosphorothioate antisense oligodeoxynucleotide specifically inhibits coxsackievirus B3 replication in cardiomyocytes and mouse hearts
- 19 April 2004
- journal article
- research article
- Published by Elsevier BV in Laboratory Investigation
- Vol. 84 (6), 703-714
- https://doi.org/10.1038/labinvest.3700083
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- Inhibition of hepadnaviral replication by polyethylenimine-based intravenous delivery of antisense phosphodiester oligodeoxynucleotides to the liverGene Therapy, 2001
- Heterogeneous Nuclear Ribonucleoprotein A1 Binds to the 3′-Untranslated Region and Mediates Potential 5′-3′-End Cross Talks of Mouse Hepatitis Virus RNAJournal of Virology, 2001
- Specific Inhibition of Coxsackievirus B3 Translation and Replication by Phosphorothioate Antisense OligodeoxynucleotidesAntimicrobial Agents and Chemotherapy, 2001
- Transgenic expression of replication-restricted enteroviral genomes in heart muscle induces defective excitation-contraction coupling and dilated cardiomyopathy.JCI Insight, 1998
- In VivoTransfer Efficiency of Antisense Oligonucleotides into the Myocardium Using HVJ–Liposome MethodBiochemical and Biophysical Research Communications, 1997
- In VivoInhibition of Hepatitis B Virus Gene Expression by Antisense Phosphorothioate OligonucleotidesBiochemical and Biophysical Research Communications, 1996
- CpG motifs in bacterial DNA trigger direct B-cell activationNature, 1995
- Direct Myocardial Injury by Enterovirus: A Central Role in the Evolution of Murine MyocarditisClinical Immunology and Immunopathology, 1993
- Evolving concepts of cause, consequence, and control in myocarditisCurrent Opinion in Cardiology, 1991
- Dilated Cardiomyopathies of the AdultNew England Journal of Medicine, 1982